Question

Difficulty: HardOrdering Laboratory Tests

A 6868-year-old man is evaluated on the inpatient medical ward for sudden-onset right leg pain and swelling. He was admitted 66 days ago for community-acquired pneumonia and was started on intravenous ceftriaxone, azithromycin, and subcutaneous unfractionated heparin for deep vein thrombosis prophylaxis. His pneumonia symptoms have significantly improved. Vital signs are within normal limits. Physical examination shows a swollen, erythematous, and tender right calf.

Laboratory StudyAdmissionCurrent
Hemoglobin13.5 g/dL13.5 \text{ g/dL}13.2 g/dL13.2 \text{ g/dL}
Platelet count280,000/μL280,000/\mu\text{L}110,000/μL110,000/\mu\text{L}
Leukocyte count11,500/μL11,500/\mu\text{L}8,200/μL8,200/\mu\text{L}

Lower extremity venous Doppler ultrasonography confirms an acute deep vein thrombosis in the right popliteal vein. Which of the following is the most appropriate next step in laboratory evaluation?

  1. A
    Serotonin release assay
  2. Enzyme-linked immunosorbent assay for platelet factor 4-heparin antibodiesAnswer
  3. C
    Peripheral blood smear
  4. D
    Fibrinogen level
  5. E
    Direct antiglobulin test

Answer

Enzyme-linked immunosorbent assay for platelet factor 4-heparin antibodies
This patient's presentation is highly suspicious for Heparin-Induced Thrombocytopenia (HIT), defined by a profound drop in platelets (>50%>50\%) and a new thrombotic event occurring 55 to 1010 days after exposure to heparin products. Because his clinical probability is high (4T score ≥\ge 4), laboratory evaluation is indicated. The most appropriate initial laboratory step is a highly sensitive immunoassay, such as an enzyme-linked immunosorbent assay (ELISA), to detect antibodies against the platelet factor 4 (PF4)-heparin complex. A negative ELISA effectively rules out HIT, while a positive result requires confirmation with a functional assay.

Step-by-Step Solution

1
Identify the clinical syndrome from the vignette
The patient has new-onset thrombocytopenia (a >50%>50\% drop from baseline) and a new thrombosis (DVT) exactly 66 days after initiating unfractionated heparin.
Recognizing this classic timeline and presentation is essential to formulating a differential diagnosis centered on Heparin-Induced Thrombocytopenia (HIT).
2
Determine the clinical pretest probability
The patient has a high clinical probability based on the 4T score (Thrombocytopenia >50%>50\%, Timing between days 55-1010, Thrombosis present, no other obvious cause).
A high pretest probability dictates that specific diagnostic testing for HIT is warranted, alongside immediate empiric changes in medical management (stopping heparin and starting a non-heparin anticoagulant).
3
Select the appropriate laboratory test sequence
Order the highly sensitive enzyme-linked immunosorbent assay (ELISA) for platelet factor 4 (PF4)-heparin antibodies first.
Diagnostic guidelines for HIT require starting with a highly sensitive immunoassay. If positive, it is followed by a highly specific functional assay (like the Serotonin Release Assay) to confirm the diagnosis.

Key Concept

Diagnostic sequencing for Heparin-Induced Thrombocytopenia (HIT)
Rate this question